Neurology · Birmingham, AL
NPI
1124115068
Since 2006
Specialty
Neurology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
509 Brookwood Blvd, Suite 101
Birmingham, AL, 35209
Phone (205) 803-2210
Groups this clinician bills Medicare through
Medicare paid, 2024
$943K
34,968 services
Medicare patients, 2024
215
Average age 64
Drug cost, 2024
$6.9M
7,458 prescriptions
Company payments, 2025
$22K
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Emily S Riser was code J2350 (injection, ocrelizumab, 1 mg), 13,200 times for 15 patients. In total Emily S Riser billed 34,968 services in 28 codes, and Medicare paid $943K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-04-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2350 Injection, ocrelizumab, 1 mg | Office | 13,200 | 15 | $39.36 | $520K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 8,049 | 26 | $0.23 | $1,824 |
| 99214 Office E&M - Established | Office | 266 | 185 | $73.03 | $19K |
| 96365 Intravenous Infusion, Hydration | Office | 156 | 25 | $39.52 | $6,165 |
| J2930 Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 124 | 14 | $3.53 | $438 |
| 96366 Intravenous Infusion, Hydration | Office | 79 | 11 | $13.72 | $1,084 |
| 96375 Injection Administration | Office | 67 | 21 | $10.49 | $703 |
| 96415 Chemotherapy Administration | Office | 32 | 14 | $18.66 | $597 |
| 96413 Chemotherapy Administration | Office | 26 | 16 | $81.40 | $2,116 |
| 99204 Office E&M - New | Office | 16 | 16 | $105.74 | $1,692 |
By year: 2022 $922K for 29,787 services; 2023 $872K for 23,915 services; 2024 $943K for 34,968 services.
Medicare prescription drug claims, 2024
In 2024, the drug Emily S Riser prescribed most often to Medicare patients was Gabapentin, with 638 prescriptions and refills. In total Emily S Riser wrote 7,458 Medicare prescriptions that cost $6.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 638 | 778 | 136 | $8,508 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 467 | 490 | 67 | $17K |
| Baclofen Generic | 435 | 677 | 98 | $9,168 |
| Clonazepam Generic | 351 | 369 | 47 | $1,622 |
| Tizanidine Hcl Generic | 298 | 410 | 64 | $3,697 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 296 | 296 | 40 | $6,502 |
| Zolpidem Tartrate Generic | 201 | 239 | 31 | $1,168 |
| Tramadol Hcl Generic | 185 | 193 | 38 | $1,440 |
| Alprazolam Generic | 182 | 208 | 22 | $972 |
| Dalfampridine Er Dalfampridine | 146 | 164 | 21 | $53K |
| Topiramate Generic | 139 | 246 | 36 | $856 |
| Duloxetine Hcl Generic | 137 | 204 | 27 | $2,063 |
| Prednisone Generic | 124 | 138 | 48 | $752 |
| Cyclobenzaprine Hcl Generic | 119 | 134 | 28 | $1,215 |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 114 | 114 | Under 11 | $483K |
Brand drugs: - claims; generic drugs: 6,656 claims; opioid claims: 557.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Emily S Riser $22K ($22K in general payments such as food, travel and fees) from 27 companies. The largest payer was TG Therapeutics, Inc. with $19K.
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. TGTX | 28 | $19K |
| Neurocrine BioSciences, Inc. NBIX | 18 | $465 |
| Biogen, Inc. BIIB | 18 | $343 |
| Alexion Pharmaceuticals, Inc. AZN | 11 | $285 |
| Novartis Pharmaceuticals Corporation NVS | 14 | $285 |
| Pfizer Inc. PFE | 15 | $252 |
| Genentech USA, Inc. ROG.SW | 10 | $232 |
| Janssen Biotech, Inc. JNJ | 6 | $225 |
| Amgen Inc. AMGN | 10 | $209 |
| Mallinckrodt Hospital Products Inc. | 11 | $176 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.